Our company was set up in 2002.We are using the advanced cold punch technology to produce spark plug which is similar to NGK and Champion technology.With such technology, the metal shell and ceramic are better protected the quality of the spark plug are more stable to get avoid from air leaking and broken.Our spark plug products are ranged into more than 100 models with an anual out put of 6 million pcs. Besides the advanced technology,we also have a strong advantage of automatical production.Most of our production device is automatical that we have very high,efficiency and stable quality.Throughout such years of developing,we have gained a good reputation at domestic motorcycle manufacturer.Furthermore,our products have been exported to South East Asia, Middle East, Australia and so on. Revolution,refine and devotion are our principal of working.Welcome to visit us and raise your demand and your comments request are our target to strive. Double Iridium Spark Plugs,Double Platinum Spark Plugs,Ngk Double Iridium Spark Plugs,Denso Double Iridium Spark Plugs LIXIN INDUSTRIAL & TRADE CO.,Limited , https://www.jmsparkplugs.com
The development of new drugs is costly, long-term, and high-risk. Because it involves people's health and life safety, the relevant drug laws and regulations in various countries have continued to improve in recent years.
It is understood that CRO (Contract Research Organization), which is currently used in the world, is a scientific institution that ensures the quality of drug research and development to reduce risks and provides professional services related to drug research and development to biopharmaceutical companies.
The joint venture company Rundong Pharmaceutical Research & Development (Shanghai) Co., Ltd. is one of the rapidly growing CRO companies in China in recent years. The company not only conducts clinical research but also conducts various training activities for clinical research institutions GCP with relevant departments; CRONOVA Co., Ltd. is the only CRO company in Japan that has passed all four standard certifications in the industry. It is also one of the best and fastest-growing CRO companies in Japan in recent years.
Guo Yunpei, vice president of the China Pharmaceutical Quality Management Association, who attended the inauguration ceremony, said that in recent years, China's pharmaceutical market has developed rapidly. However, due to fierce market competition, CRO companies have had a mixed situation, and local companies with genuine strict quality standards have become paralyzed. Few. The successful cooperation between Rundong Pharmaceutical Research and Development (Shanghai) Co., Ltd. and Japan's Cronova Inc., not only in terms of market development, quality standards, and resource sharing, but also complements the advantages of the pharmaceutical industry in both China and Japan. The exchanges and developments provide technical support for high-quality pharmaceutical products entering the market as soon as possible.
China and Japan Strengthen Cooperative Research in Pharmaceutical R&D
Rundong Keruohua Pharmaceutical Research & Development (Shanghai) Co., Ltd., a joint venture of Chinese and Japanese pharmaceutical R&D companies, was established in Shanghai. The establishment of this company will strengthen cooperation research between the two countries in the field of pharmaceutical R&D.